Vista Pharmaceuticals (BOM:524711) Short Interest


BOM:524711 Vista Pharmaceuticals Ltd BOM:524711
47 GF Score
Price ₹7.28
GF Value ₹6.05
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Vista Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


BOM:524711 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vista Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's Short Interest falls into.


BOM:524711
47GF Score
Vista Pharmaceuticals Ltd BOM:524711
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vista Pharmaceuticals (BOM:524711) Overvalued in 2026?

Based on GuruFocus' analysis, Vista Pharmaceuticals stock appears to be overvalued. The current stock price of ₹7.28 is trading 20.3% above its estimated GF Value™ of ₹6.05. GuruFocus considers Vista Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:524711:

  • Short Interest:
  • GF Value™: ₹6.05 vs. price of ₹7.28 (20.3% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:524711 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vista Pharmaceuticals Business Description

Address Kakateeya Hills, Plot No. 104, Ravindra Co Operative Society, Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian company engaged in a single operating segment, which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within its domestic market.
47GF Score

Get the complete analysis for BOM:524711

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.28
Price
₹6.05
GF Value